Qingdao Vland Biotech Co Ltd
Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological … Read more
Qingdao Vland Biotech Co Ltd (603739) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.013x
Based on the latest financial reports, Qingdao Vland Biotech Co Ltd (603739) has a cash flow conversion efficiency ratio of 0.013x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥24.29 Million) by net assets (CN¥1.90 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Qingdao Vland Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Qingdao Vland Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Qingdao Vland Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qingdao Vland Biotech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ta Ann Holdings Bhd
KLSE:5012
|
0.041x |
|
Concord International Securities Co Ltd
TWO:5864
|
-0.140x |
|
CHRCF
PINK:CHRCF
|
N/A |
|
Stockmann Oyj Series B
LSE:0MW2
|
-0.243x |
|
Sunteck Realty Limited
NSE:SUNTECK
|
-0.051x |
|
Anhui Huangshan Capsule Co Ltd
SHE:002817
|
0.030x |
|
VITZROCELL Co.Ltd
KQ:082920
|
0.016x |
|
CPH Chemie und Papier Holding
SW:CPHN
|
0.023x |
Annual Cash Flow Conversion Efficiency for Qingdao Vland Biotech Co Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of Qingdao Vland Biotech Co Ltd from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.87 Billion | CN¥195.41 Million | 0.104x | +24.19% |
| 2023-12-31 | CN¥1.83 Billion | CN¥153.59 Million | 0.084x | +53.08% |
| 2022-12-31 | CN¥1.73 Billion | CN¥95.31 Million | 0.055x | +3.50% |
| 2021-12-31 | CN¥1.69 Billion | CN¥89.51 Million | 0.053x | -65.76% |
| 2020-12-31 | CN¥1.12 Billion | CN¥173.00 Million | 0.155x | +145.11% |
| 2019-12-31 | CN¥1.03 Billion | CN¥65.33 Million | 0.063x | -53.40% |
| 2018-12-31 | CN¥631.38 Million | CN¥85.75 Million | 0.136x | -33.98% |
| 2017-12-31 | CN¥592.53 Million | CN¥121.90 Million | 0.206x | -25.70% |
| 2016-12-31 | CN¥557.97 Million | CN¥154.49 Million | 0.277x | +93.62% |
| 2015-12-31 | CN¥519.36 Million | CN¥74.27 Million | 0.143x | +13.88% |
| 2014-12-31 | CN¥466.26 Million | CN¥58.55 Million | 0.126x | -- |